Completed PHASE4 INTERVENTIONAL 2-arm NCT03544827

The Effects of Low Dose Atropine on Choroidal Thickness

Sponsor: State University of New York College of Optometry

Conditions Myopia

Interventions Atropine

Updated 5 times since 2018 Last updated: Feb 11, 2019 Started: May 21, 2018 Primary completion: Feb 8, 2019 Completion: Feb 8, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Myopia and is currently completed. State University of New York College of Optometry leads this study, which shows 5 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Mar 2019 — Jan 2021 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Jul 2018 — Mar 2019 [monthly]

Recruiting PHASE4

First recorded

May 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

State University of New York College of Optometry

Data source: State University of New York College of Optometry

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States